SEC Comment Letter for vTv Therapeutics Inc. (VTVT) (CIK 0001641489) (VTVT) — Jul 11, 2019
vTv Therapeutics Inc. (VTVT) (CIK 0001641489)
Date: July 11, 2019 · CIK: 0001641489 · Accession: 0000000000-19-011036
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232571
Letter
July 11, 2019 Stephen L. Holcombe Chief Executive Officer vTv Therapeutics Inc. 4170 Mendenhall Oaks Pkwy High Point, NC 27265 Re:vTv Therapeutics Inc. Registration Statement on Form S-3 Filed July 5, 2019 File No. 333-232571 Dear Mr. Holcombe: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Lawrence G. Wee, Esq.
Show Raw Text
July 11, 2019
Stephen L. Holcombe
Chief Executive Officer
vTv Therapeutics Inc.
4170 Mendenhall Oaks Pkwy
High Point, NC 27265
Re:vTv Therapeutics Inc.
Registration Statement on Form S-3
Filed July 5, 2019
File No. 333-232571
Dear Mr. Holcombe:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tonya K. Aldave at (202) 551-3601 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Lawrence G. Wee, Esq.